Donal, John B.
HRN: 22-47-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/14/2023
01/20/2023
IV
500mg
Q6hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes